Cardiovascular research on PGI2, 6-keto-PGF1 alpha, PGF2 alpha, and 15(S)-15-methyl-PGF2 alpha.
D015121:6-Ketoprostaglandin F1 alpha; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002260:Carboprost / Q000494:pharmacology*; D002339:Carotid Arteries / Q000502:physiology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology; D011464:Epoprostenol / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006339:Heart Rate / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology*; D011460:Prostaglandins F / Q000494:pharmacology*; D011461:Prostaglandins F, Synthetic / Q000494:pharmacology*; D012119:Respiration / Q000187:drug effects
D011453:Prostaglandins; D011460:Prostaglandins F; D011461:Prostaglandins F, Synthetic; D015121:6-Ketoprostaglandin F1 alpha; D002260:Carboprost; D011464:Epoprostenol; D009638:Norepinephrine; D004837:Epinephrine